Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Severe Hypogammaglobulinemia (IgG) During Efgartigimod Therapy in Neurological Practice: A Real-World Case Series.
Tick-Borne Infection as a Precipitant of Guillain-Barré Syndrome: A Case of Lyme Neuroborreliosis.
Assessing optic nerve integrity in optic neuritis with conventional magnetic resonance imaging.
Pediatric Guillain-Barré Syndrome.
Adjunctive Non-Disease-Modifying Therapies in Multiple Sclerosis: Immunometabolic, Neuroprotective and Remyelination-Oriented Approaches.
Video Head Impulse Testing in Relapsing Remitting Multiple Sclerosis: Evaluation of Canal Gains, Asymmetry, and Corrective Saccades with Cerebellar Lesions.
Which medication improves fatigue in patients with multiple sclerosis (MS)?: a systematic review and network meta-analysis.
Should autologous HSCT be a first-line option in highly active MS? No.
Human genetic and immunological determinants of Epstein-Barr virus-driven disease.
Examining the Impact of Perceived and Objective Cognitive Function on Social Participation in Individuals with Multiple Sclerosis.
Novel Homozygous Variant Impairs Brain Development: Case Report and Literature Review.
Pathological signatures of white matter lesions in multiple sclerosis versus stroke: a synthetic MRI study.
First-in-Human Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single and Multiple Ascending Oral Doses of BIIB091, an Oral BTK Inhibitor, in Healthy Adult Participants.
Multiple Sclerosis Drug Fingolimod Exhibits Antibacterial Activity through Bacterial Membrane Permeabilization.
Intrathecal IgM species as potential prognostic biomarkers in relapsing-remitting multiple sclerosis.
Isoform-specific roles of QKI-6 and QKI-7 direct Schwann cell lineage progression and enhance peripheral nerve regeneration.
How are interleukin-6 receptor antagonists shaping the future of neuromyelitis optica spectrum disorder?
Bruton's Tyrosine Kinase Inhibitors in Multiple Sclerosis: Mechanistic Considerations Across Relapsing and Progressive Disease.
Neurophysiological, imaging and neurobiological markers of central fatigue in multiple sclerosis.
Home Monitoring of Visual Functions in Neuro-Ophthalmic Diseases Using an AI-Assisted Virtual Reality Platform.
Associations between Paramagnetic Rim Lesions and Gadolinium Contrast Permeability of Perivascular Spaces in Patients with Multiple Sclerosis: A T1 mapping study.
Astrocyte Heterogeneity in Multiple Sclerosis From Reactive Glia to Therapeutic Targets.
Statin Therapy Protects White Matter in Cerebral Small Vessel Disease Independent of Lipid-Lowering: Biomarker and Neuroimaging Evidence.
Case Report and Literature Review of Spinal Anesthesia-Related Peroneal Nerve Injury Complicated with Diabetic Foot Peripheral Neuropathy.
Rituximab Beyond Oncology: Targeting B-Cell-Mediated Immunomodulatory Therapy in Neurodegenerative and Neuropsychiatric Disorders.
Pages
« first
‹ previous
…
971
972
973
974
975
976
977
978
979
…
next ›
last »